TEMENOS
17.5.2022 09:32:08 CEST | Business Wire | Press release
Temenos (SIX: TEMN) today launched Temenos CEO Navigator, a subscription-based customer value benchmarking and advisory service that gives C-level banking executives unique insights on how to optimize their technology investments to drive business value.
The consultative, survey-based strategic service enables banks to discover the drivers of performance and value creation, and provides the business and IT metrics they need to track and improve profitability. It is built on Temenos’ proprietary value benchmark program with over 100 participating retail, corporate and private banks from across the world.
The CEO Navigator uses over 50,000 data points on financial and operational metrics as well as qualitative best practices across the entire banking value chain irrespective of what solutions the bank runs, to provide banking leaders exclusive insights and Temenos industry know-how. They can assess how specific banking best practices and solution capabilities drive high performance in terms of healthier cost-income ratios and improved returns on equity.
Temenos CEO Navigator’s analysis has revealed that banks that have digitally transformed their business and moved away from legacy systems are able to differentiate across five key pillars: innovation and growth; customer centricity; operational efficiency; risk and compliance; and advanced analytics. Temenos CEO Navigator tracks and provides metrics and best practices across these five pillars to help drive banking performance. For example, if a bank improves its proportion of IT spend on growth and innovation to top quartile value of 58% then it should also have a lower cost to income ratio and see an increase in profitability.
Kanika Hope, Chief Strategy Officer, Temenos, said: “Temenos CEO Navigator is an industry-leading customer advisory service that distills Temenos’ almost 30 years of banking IP into powerful business insights for our clients. Every insight delivered to the bank is completely software-agnostic and based on interactive sessions between the bank’s executives and our strategy consultants across the entire banking value chain. This program is unique in terms of reach, number and type of banks and the depth of data, and offers executive teams a blueprint on how to run a successful bank.”
After analyzing over 100 banks, the Temenos CEO Navigator reveals that top performing banks using the Temenos open platform for composable banking have achieved industry-leading cost-income ratios, which are half the industry average, and returns on equity, which are almost three times higher than the industry average.
Dr. Diane Karusisi, CEO, Bank of Kigali, commented: “Everyone expects Temenos to develop and sell banking software but nobody expects Temenos to consult for you. We benefited from a wealth of statistics and insights on banks worldwide as part of the Temenos CEO Navigator. This has helped us understand, accelerate, and optimize the business value created by our technology investment.”
Azfar Karimuddin, Chief Information Officer, Canadian Western Bank, said: “Our leadership team found the information and analysis provided very powerful. It helped answer questions about our technology investment and provided industry context to inform and validate our efforts.”
As part of the Temenos CEO Navigator service, banks receive a customized report comparing their business performance with their peers, annual updates of the report as well as access to the overall benchmark trends and insights that will be updated every year. The bank also becomes part of the Temenos Ambassador Program gaining automatic access to the Temenos Community Forum, the company’s flagship event. For more information please visit here .
– Ends –
About Temenos
Temenos AG (SIX: TEMN) is the world’s leader in banking software. Over 3,000 banks across the globe, including 41 of the top 50 banks, rely on Temenos to process both the daily transactions and client interactions of more than 1.2 billion banking customers. Temenos offers cloud-native, cloud-agnostic and AI-driven front office, core banking, payments and fund administration software enabling banks to deliver frictionless, omnichannel customer experiences and gain operational excellence.
Temenos software is proven to enable its top-performing clients to achieve cost-income ratios of 26.8% half the industry average and returns on equity of 29%, three times the industry average. These clients also invest 51% of their IT budget on growth and innovation versus maintenance, which is double the industry average, proving the banks’ IT investment is adding tangible value to their business.
For more information, please visit www.temenos.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220517005618/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SOLUM and Simbe Expand European Collaboration to Advance Intelligent Store Operations5.3.2026 08:00:00 CET | Press release
SOLUM (KOSPI: 248070) and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. The collaboration was highlighted at EuroShop, where Simbe’s Store Intelligence™ platform was demonstrated live at the SOLUM booth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304620371/en/ SOLUM and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. (Image: SOLUM) Simbe recently introduced Tally 4.0, the next generation of their autonomous shelf-scanning robot, reflecting the company’s continued evolution in retail shelf digitization, incorporating extended runtime, enhanced edge computing, and advanced vision capabilities. Designed to deliver deeper shelf coverag
Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology5.3.2026 08:00:00 CET | Press release
Breakthrough designation means Cognita™ will engage in prioritized interaction with FDA regarding clearance of device designed to help solve the radiology capacity bottleneck Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing generative vision-language models (VLMs) for radiology, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for Cognita Chest X-Ray (CXR)™1 across multiple critical indications. Cognita CXR is an industry-first generative vision-language model designed to assist radiologists in the interpretation of chest X-rays and is the first radiology generative AI model, and one of very few radiology AI solutions, to be granted this designation2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304633206/en/ Cognita™ operates as the AI business unit of Mosaic Clinical Technologies™, a
Cielo Advances Resilient Remote Connectivity for Its Nationwide Payment Terminal Fleet With Thales5.3.2026 08:00:00 CET | Press release
Cielo, one of Brazil’s leading payment service providers, is piloting remote connectivity management for its point-of-sale (POS) terminals across the country, in partnership with Thales. By deploying Thales’s eSIM connectivity management platform based on the latest GSMA SGP.32 IoT standard, Cielo is accelerating its transition from manual, on-site SIM management to fully remote, secure and resilient connectivity. For Cielo, connectivity is mission critical. When payment terminals lose network access, transactions stop. To strengthen operational resilience and enhance merchant experience, Cielo is modernizing its connectivity architecture across its terminal fleet. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304089321/en/ Cielo advances resilient remote connectivity for its nationwide payment terminal fleet with Thales. Using Thales’s eSIM technology as part of this strategy, Cielo can remotely switch mobile network op
GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.5.3.2026 08:00:00 CET | Press release
GAIA, the pioneer in evidence-based digital therapeutics and Daiichi Sankyo Europe, today announced an exclusive strategic partnership to commercialize lipodia upon regulatory approval1. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224658973/en/ Dr. Mario Weiss, Founder & CEO of GAIA AG This digital therapeutic is designed to support adults living with hypercholesterolemia. The comprehensive collaboration brings together GAIA’s long-standing expertise in developing clinically validated non-pharmacological interventions with Daiichi Sankyo’s highly scientific experience in cardiovascular risk management and health. Together, the partners - both members of the German Association of Research-Based Pharmaceutical Companies (vfa) - aim to address a persistent gap in chronic care: leveraging digital technologies to make a difference in patients’ lives by supporting sustainable, long-term behaviour change. Expanding Cardiovasc
Galderma Delivers Record 2025 Results With Net Sales of 5.207 Billion USD, up 17.7% at Constant Currency1, and Core EBITDA2 of 1.211 billion USD, Growing 18.9% at Constant Currency5.3.2026 07:00:00 CET | Press release
Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2025. Record net sales of 5,207 million USD, surpassing 5 billion USD in a year for the first time and representing 17.7% year-on-year growth on a constant currency1 basis, primarily driven by volume. Broad-based net sales growth, growing double-digits in both International markets and the U.S. Outperforming the market in each product category, with strong net sales growth in Injectable Aesthetics (11.5%), Dermatological Skincare (9.3%) and Therapeutic Dermatology (50.2%), all year-on-year at constant currency. Strong launch momentum across future growth drivers, including Nemluvio® (nemolizumab) delivering 452 million USD in net sales; Relfydess™ (RelabotulinumtoxinA) outperforming expectations in 17 International markets; Sculptra® gaining significant market share in its first year in China; and continued new produ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
